Back

CMR for risk stratification in non-ischaemic cardiomyopathies (HCM, Sarcoid, DCM, Amyloid).

4 May 2019 (09:50 - 10:05)
Organised by:
Congress Presentation Part of: CMR through evidence and guidelines Cardiac Magnetic Resonance (CMR) EACVI Premium Access EuroCMR 2019

About the speaker

Photo
Doctor Ron Jacob

Lancaster Heart and Vascular Institute, Lancaster (United States of America)

4 More presentations in this session

Presentation thumbnail
CMR in acute coronary syndromes: current guidelines.
Doctor S. Raman (Columbus, US)
Slides Video
Presentation thumbnail
Clinical recommendations for CMR parametric mapping.
Doctor M. Salerno (Stanford, US)
Presentation thumbnail
How trials in CMR have changed clinical practice.
Professor J. Greenwood (Melbourne, AU)
Presentation thumbnail
Indications that should be included in new CMR guidelines.
Professor J. Schulz-Menger (Berlin, DE)
Slides Video

Access the full session

Session thumbnail
CMR through evidence and guidelines

The Event

Event poster

EuroCMR 2019

4 May 2019 09:50 CET
You may be interested in
thumbnail
Congress Presentation
Use of CMR in the assessment of cardiovascular reserve in patients treated with CAR-T therapy
thumbnail
Congress Presentation
The role of cardiac magnetic resonance in cardiac arrest without initial underlying cause
thumbnail
Congress Presentation
Cardiac magnetic resonance imaging for the diagnosis of cardiac amyloidosis in patients with heart failure

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources